Abstract

Lysine acetylation is a post-translational modification that is conserved from bacteria to humans. It is catalysed by the activities of lysine acetyltransferases, which use acetyl-CoA as the acetyl-donor molecule, and lysine deacetylases, which remove the acetyl moiety. Recently, it was reported that YcgC represents a new prokaryotic deacetylase family with no apparent homologies to existing deacetylases (Tu et al., 2015). Here we report the results of experiments which demonstrate that YcgC is not a deacetylase.

Data availability

All data generated or analyses during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Magdalena Kremer

    Institute for Genetics, CECAD Research Center, University of Cologne, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.
  2. Kuhlmann Nora

    Institute for Genetics, CECAD Research Center, University of Cologne, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Marius Lechner

    Institute for Genetics, CECAD Research Center, University of Cologne, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Linda Baldus

    Institute for Genetics, CECAD Research Center, University of Cologne, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. Michael Lammers

    Institute for Genetics, CECAD Research Center, University of Cologne, Cologne, Germany
    For correspondence
    michael.lammers@uni-koeln.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4168-4640

Funding

Deutsche Forschungsgemeinschaft (LA 2984/3-1)

  • Michael Lammers

Deutsche Forschungsgemeinschaft (CECAD)

  • Magdalena Kremer
  • Kuhlmann Nora
  • Marius Lechner
  • Linda Baldus
  • Michael Lammers

Boehringer Ingelheim Fonds (Exploration Grant)

  • Kuhlmann Nora

Deutsche Forschungsgemeinschaft (Cologne Graduate School of Ageing Research)

  • Magdalena Kremer

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2018, Kremer et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Magdalena Kremer
  2. Kuhlmann Nora
  3. Marius Lechner
  4. Linda Baldus
  5. Michael Lammers
(2018)
Comment on "YcgC represents a new protein deacetylase family in prokaryotes"
eLife 7:e37798.
https://doi.org/10.7554/eLife.37798

Share this article

https://doi.org/10.7554/eLife.37798

Further reading

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Joar Esteban Pinto Torres, Mathieu Claes ... Yann G-J Sterckx
    Research Article

    African trypanosomes are the causative agents of neglected tropical diseases affecting both humans and livestock. Disease control is highly challenging due to an increasing number of drug treatment failures. African trypanosomes are extracellular, blood-borne parasites that mainly rely on glycolysis for their energy metabolism within the mammalian host. Trypanosomal glycolytic enzymes are therefore of interest for the development of trypanocidal drugs. Here, we report the serendipitous discovery of a camelid single-domain antibody (sdAb aka Nanobody) that selectively inhibits the enzymatic activity of trypanosomatid (but not host) pyruvate kinases through an allosteric mechanism. By combining enzyme kinetics, biophysics, structural biology, and transgenic parasite survival assays, we provide a proof-of-principle that the sdAb-mediated enzyme inhibition negatively impacts parasite fitness and growth.

    1. Biochemistry and Chemical Biology
    Jianheng Fox Liu, Ben R Hawley ... Samie R Jaffrey
    Tools and Resources

    N 6,2’-O-dimethyladenosine (m6Am) is a modified nucleotide located at the first transcribed position in mRNA and snRNA that is essential for diverse physiological processes. m6Am mapping methods assume each gene uses a single start nucleotide. However, gene transcription usually involves multiple start sites, generating numerous 5’ isoforms. Thus, gene-level annotations cannot capture the diversity of m6Am modification in the transcriptome. Here, we describe CROWN-seq, which simultaneously identifies transcription-start nucleotides and quantifies m6Am stoichiometry for each 5’ isoform that initiates with adenosine. Using CROWN-seq, we map the m6Am landscape in nine human cell lines. Our findings reveal that m6Am is nearly always a high stoichiometry modification, with only a small subset of cellular mRNAs showing lower m6Am stoichiometry. We find that m6Am is associated with increased transcript expression and provide evidence that m6Am may be linked to transcription initiation associated with specific promoter sequences and initiation mechanisms. These data suggest a potential new function for m6Am in influencing transcription.